IQV

stock Healthcare Diagnostics & Research

IQVIA

$181.94 +1.30 (+0.72%) Delayed · quoted 47d ago

Mixed 49% Steady

What the indicators say

Mixed 3 of 5 trend signals bullish

Momentum · RSI 14 Leaning bullish

0oversold 30overbought 70100

RSI 59 — firm momentum, not yet overbought.

EMA 21 $174.33

Above

Near-term trend is up

SMA 50 $170.87

Above

Medium-term trend is up

SMA 200 $195.82

Below

Long-term trend is down

50 / 200-day

Death cross

50-day below the 200-day — bearish

Supertrend $163.20

Uptrend

Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range

Low $174.12 High $182.32

Open: $181.94; +0.72%
Close: $181.94; +0.72%

52-week range where the price sits across its year

52w low $136.41 52w high $247.04

Current: $181.94
Prev close: $180.64

Volume 0.77× the 3-month average

0 avg 2× avg

Today: 1.27M
3-mo avg: 1.64M

Earningscalendar synced from Yahoo 57d ago

Most recent: May 577 days ago
Next expected: Jul 21in 0 days

Recent earnings dates

May 5 77 days ago
Feb 5 166 days ago
Oct 28, 2025 266 days ago
Jul 22, 2025 364 days ago

Past earnings dates come from IQV’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), IQV’s fundamentals read as fair overall.

P/E ratio Strong

22.6x

At 22.6x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair

0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair

8.3%

A 8.3% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong

20.9%

A 20.9% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair

4.5%

A 4.5% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Weak

3.59

At 3.59, the company leans heavily on borrowing, which adds risk if results weaken.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak

0.75

At 0.75, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair

+5.9%

Revenue grew 5.9% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak

-0.9%

Net income fell 0.9% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$13.9B	$14.4B	$15.0B	$15.4B	$16.3B
Net income	$966.0M	$1.1B	$1.4B	$1.4B	$1.4B
Diluted EPS	$4.95	$5.72	$7.29	$7.49	$7.84
Dividend / share	—	—	—	—	—
Total assets	$24.7B	$25.3B	$26.7B	$26.9B	$29.9B
Total liabilities	$18.6B	$19.6B	$20.6B	$20.8B	$23.3B
Shareholder equity	$6.0B	$5.8B	$6.1B	$6.1B	$6.5B

	Q2-2024	Q3-2024	Q4-2024	Q1-2025	Q2-2025	Q3-2025	Q4-2025	Q1-2026
Revenue	$3.8B	$3.9B	$4.0B	$3.8B	$4.0B	$4.1B	$4.4B	$4.2B
Net income	$363.0M	$285.0M	$437.0M	$249.0M	$266.0M	$331.0M	$514.0M	$274.0M
Diluted EPS	$1.97	$1.55	$2.41	$1.40	$1.54	$1.93	$2.97	$1.61
Dividend / share	—	—	—	—	—	—	—	—

Leadershipsynced from SEC 55d ago

Danhakl John G Director
Fasano Jim Director
Goggins Colleen A Director
Kaelin William G Jr Director
Leonard John M Director
Stamps Sheila A Director
Wims Morris Leslie Director

Officers and board are drawn from IQV’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

May 28 +9.3% one-day move
May 5 +9.6% one-day move
Apr 23 New 6-month low (-34% off peak)
Apr 23 −8.3% one-day move
Apr 23 Officer or director change reported in an 8-K
Feb 26 +5.4% one-day move
Feb 12 New 6-month low (-31% off peak)
Feb 10 −5.3% one-day move
Feb 5 −10.7% one-day move
Feb 3 −11.9% one-day move
Nov 5, 2025 Officer or director change reported in an 8-K
Oct 1, 2025 +7.3% one-day move
Sep 2, 2025 Officer or director change reported in an 8-K
Jul 22, 2025 +17.9% one-day move

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.